Committee Testimony and Witness Signup
SB0394 - Statewide Targeted Overdose Prevention (STOP) Act of 2022
Finance 2/17/2022 1:00:00 PM
Health and Government Operations 3/30/2022 1:30:00 PM
As of: 11/21/2024 11:09:40 AM
| Name | Organization | Position | Testimony | Committee |
|---|---|---|---|---|
| President, President | FAV |
In Person - Oral Testimony |
FIN | |
| Townsend, Pegeen A. | MedStar Health | FAV | SB 394 - Statewide Targeted Overdose Prevention ST | FIN |
| Delbridge, Theodore | Maryland Institute for EMS Systems (MIEMSS) | FAV | SB 394_Statewide Targeted Overdose Prevention (STO | FIN |
| Taylor, Ralph "Doug" | Somerset County Government | FAV | SB394- STOP Act Support .pdf | FIN |
| Park, Ju Nyeong | FAV | Park LOS SB394.pdf | FIN | |
| Wall, Sarah | R Street Institute | FAV | Final - MD SB 394 - testimony - Sarah Wall.pdf | FIN |
| Nibber, D'Paul | Maryland Association of Counties (MACo) | FAV |
In Person - Oral Testimony SB0394-FIN_MACo_SUP.pdf |
FIN |
| Russell, Erin | Maryland Department of Health | FAV |
In Person - Oral Testimony |
FIN |
| Rickard, Robin | Opioid Operational Command Center | FAV |
In Person - Oral Testimony |
FIN |
| Grollmes, Joshua | MATOD | FWA | MATOD - SB 394 FWA - Naloxone.pdf | FIN |
| Kasemeyer, Pam | FAV | No Testimony | FIN | |
| Ciekot, Ann | NCADD-Maryland | FWA |
In Person - Oral Testimony NCADD-MD - SB 394 FWA - Naloxone.pdf |
FIN |
| Shaklee, Christina | FWA | Copy of Statewide Targeted Overdose Prevention Act | FIN | |
| Beskid, Jennifer | Department of Public Safety and Correctional Services | FWA | SB0394 - Naloxone - SWA.pdf | FIN |
| Gudlavalleti, Rajani | Baltimore Harm Reduction Coalition | FWA | SB394_BHRC_FAV WITH AMENDMENT_STOP ACT.pdf | FIN |
| Shek, Heather | Maryland Department of Health | FAV | 9a - SB 394 - X - FIN - MDH - LOS - ADMINISTRATION | FIN |
| Hames, Shari | FAV | SB394_HamesRN.pdf | FIN | |
| (MD), State of Maryland | FAV | 9b - SB 394 - X - FIN - OOCC - LOS.pdf | FIN | |
| Livshin, Michelle | On Our Own of Maryland, Inc. | FWA | 2022 -SB394-FAVAMEND-OOOMD.pdf | FIN |
| State of, Maryland | FWA | 9c - SB 394 - FIN - MACHO LOSWA.pdf | FIN | |
| Dorrien, Erin | Maryland Hospital Association | INFO | SB 394 Statewide Targeted Overdose Prevention (STO | FIN |
| Burrell, Deborah | Strengthening the Mid-Atlantic Region for Tomorrow/Burrell International Group | FAV | SB394_SMART_FAV.pdf | FIN |
| Doyle, Lori | FWA | SB 394-CBH-FWA.pdf | FIN | |
| Martin, Dan | Mental Health Association of Maryland | FAV | SB0394 STOP Act.pdf | FIN |
| Whitaker, Jake | FWA |
In Person - Oral Testimony Senate Bill 394 - Statewide Targeted Overdose Pre |
FIN | |
| Coble, Annie | Johns Hopkins | INFO | SB394 - Hopkins - LOI.pdf | FIN |
| Evans Arthurs, Maureen | Howard County Government | FAV | CEBall_SB 394_ Support_STOP Act 2022_Final.pdf | FIN |
| Testimony, All | N/A | Merged Testimony as of 2-17-2022 at 1005 AM | FIN | |
| President, President | FAV |
In Person - Oral Testimony |
HGO | |
| Rosen-Cohen, Nancy | NCADD-Maryland | FAV | NCADD-MD - SB 394 FWA - Naloxone - House.pdf | HGO |
| Fry, Donald | Greater Baltimore Committee | FAV | SB0394 - 3.30.22 -- (Opposite) Statewide Targeted | HGO |
| Beskid, Jennifer | Department of Public Safety and Correctional Services | FAV | SB0394 (3rd Reader) - Opioid Reversal Drug - SUP.p | HGO |
| Dorrien, Erin | Maryland Hospital Association | INFO | SB 394 STOP Act Crossover Testimony.pdf | HGO |
| Nibber, D'Paul | Maryland Association of Counties (MACo) | FAV | SB0394-HGO_MACo_SUP.pdf | HGO |
| Grollmes, Joshua | MATOD | FAV | MATOD - SB 394 FWA - Naloxone - House.pdf | HGO |
| Whitaker, Jake | FAV |
In Person - Oral Testimony Senate Bill 394 - Statewide Targeted Overdose Prev |
HGO | |
| Shek, Heather | Maryland Department of Health | FAV | 12a - X - SB 394 - HGO - MDH - LOS.docx.pdf | HGO |
| (MD), State of Maryland | FAV | 12b - SB 394 - HGO - OOCC - LOS.pdf | HGO | |
| State of, Maryland | FAV | SB 394 - HGO - MACHO - LOSAA.pdf | HGO | |
| Townsend, Pegeen A. | MedStar Health | FAV | SB 394 - Statewide Targeted Overdose Prevention ST | HGO |